Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Opinion
Video
Vitiligo Repigmentation Challenges and Evaluating Treatment Success
Author(s):
Key Takeaways
- Sustained repigmentation in vitiligo is challenged by the disease's chronic nature and variability in patient response to treatments.
- Treatment success is evaluated by the extent and stability of repigmentation, patient satisfaction, and quality of life improvements.
The panelist discusses the primary challenges in vitiligo repigmentation, including maintaining patient compliance through lengthy treatment courses and managing expectations around partial repigmentation outcomes, which require careful monitoring and ongoing patient education about realistic goals while assessing success through standardized documentation of even minimal improvements to inform treatment adjustments.
Video content above is prompted by the following:
- What are the biggest challenges in achieving sustained repigmentation in vitiligo? How do you guide patients through these hurdles?
- How do you evaluate that treatment success when they’re only experiencing partial repigmentation?
Related Videos
Related Content
